Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-16 Schuchart Aaron Chief Business Officer Grant or award · Employee Stock Option (right to buy) +100,000 100,000
2017-04-21 Quinn Anthony interim Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +24,000 24,000
2017-03-20 York Charles N II Chief Financial Officer and VP Grant or award · Employee Stock Option (right to buy) +90,000 90,000
2017-03-20 TYLER JOSEPH E VP, Manufacturing Grant or award · Employee Stock Option (right to buy) +39,000 39,000
2017-03-20 Rowlinson Scott W VP, Research Grant or award · Employee Stock Option (right to buy) +60,000 60,000
2017-03-20 Lowe David George CEO and President Grant or award · Employee Stock Option (right to buy) +160,000 160,000
2017-02-15 York Charles N II Chief Financial Officer and VP Purchase +2,000 $4.28 $9K 12,828
2016-08-15 York Charles N II Chief Financial Officer and VP Purchase +2,000 $3.99 $8K 10,828
2016-04-12 Novartis Bioventures Ltd 10% owner Conversion +2,010,924 2,010,924
2016-04-12 Novartis Bioventures Ltd 10% owner Purchase +300,000 $10.00 $3.0M 2,310,924
2016-04-12 Novartis Bioventures Ltd 10% owner Conversion · Series A Preferred Stock −890,476 0
2016-04-12 Novartis Bioventures Ltd 10% owner Conversion · Series B Preferred Stock −1,120,448 0

Page 19 of 19 · 372 trades